Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024)
Biosensors · 2024
DOI: 10.3390/bios14090419 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2024. Verfasst von Dan-Ni Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China. Hauptthemen laut MEDLINE: Point-of-Care Testing, Blood Glucose Self-Monitoring, Biosensing Techniques. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China, Chongqing Shapingba Medical Scientific Research Project (Joint project of Chongqing Shapingba Health Commission and Science and Technology Bureau), China, Postdoctoral Science Foundation of Chongqing, China.
Abstract (Originalsprache)
Point-of-care testing (POCT) is a contemporary diagnostic approach characterized by its user-friendly nature, cost efficiency, environmental compatibility, and lack of reliance on professional experts. Therefore, it is widely used in clinical diagnosis and other analytical testing fields to meet the demand for rapid and convenient testing. The application of POCT technology not only improves testing efficiency, but also brings convenience and benefits to the healthcare industry. The personal glucose meter (PGM) is a highly successful commercial POCT tool that has been widely used not only for glucose analysis, but also for non-glucose target detection. In this review, the recent advances from 2020 to 2024 in non-glucose target analysis for PGMs as POCT devices are summarized. The signal transduction strategies for non-glucose target analysis based on PGMs, including enzymatic transduction, nanocarrier transduction (enzyme or glucose), and glucose consumption transduction are briefly introduced. Meanwhile, the applications of PGMs in non-glucose target analysis are outlined, encompassing biomedical, environmental, and food analysis, along with other diverse applications. Finally, the prospects of and obstacles to employing PGMs as POCT tools for non-glucose target analysis are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.
- The Central Laboratory, The Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.
Förderung
- Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China
- Chongqing Shapingba Medical Scientific Research Project (Joint project of Chongqing Shapingba Health Commission and Science and Technology Bureau), China
- Postdoctoral Science Foundation of Chongqing, China
- Chongqing Medical and Pharmaceutical College, China
- Chongqing Health Commission and Science and Technology Bureau
- Chongqing Medical Young Top-notch Talent Project, China
- Chongqing Shapingba Health Commission and Science and Technology Bureau
- Chongqing Postdoctoral Science Foundation, China
Zitieren
APA
Yang, D. N., Geng, S., Jing, R., & Zhang, H. (2024). Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024). Biosensors. https://doi.org/10.3390/bios14090419
Vancouver
Yang DN, Geng S, Jing R, Zhang H. Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024). Biosensors. 2024. doi:10.3390/bios14090419
BibTeX
@article{Yang2024,
author = {Yang, Dan-Ni and Geng, Shan and Jing, Rong and Zhang, Hao},
title = {Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024)},
journal = {Biosensors},
year = {2024},
doi = {10.3390/bios14090419}
}
EUVIMED